in Kooperation mit der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten e.V.

Sie sind hier



We are inviting applications from enthusiastic post-doctoral candidates (2-year position) or PhD student (3-year position) to participate in our project supported by the French National Agency (ANR JCJC).

CIRI, Center for
Infectiology Research
UMR5308 - Université
Lyon 1– ENS Lyon, France
Team lead by Dr M. Dreux

APPLICATION BY: 15th March 2020

In der Fakultät für Mathematik, Informatik und Naturwissenschaften ist zum nächstmöglichen Zeitpunkt eine W1 Juniorprofessur für INFEKTIONSBIOLOGIE zu besetzen. Kennziffer JP 303. Aufgabengebiet: Die Forschung der Professur soll sich auf zelluläre und molekulare Aspekte des dynamischen Zusammenspiels zwischen nicht-humanen Pathogenen und ihren Wirtszellen beziehen.

Deadline: 20. Februar 2020

The Institute of Immunology is inviting applications for the position of University Professor for Systems Biology of Chronic Infections (comparable to salary grade W2 LBesG, six-year contract with tenure-track). We are looking for a researcher with a doctorate who will represent the advertised field in research and teaching (including further scientific training), thereby expanding the immunological profile of the University Medical Center. The successful applicant is to join our faculty at the earliest possible date.

Deadline: February 20. 2020

We are looking for a talented and highly motivated PhD student to join the research group of PD Dr. Hanna-Mari Baldauf at the Max von Pettenkofer-Institute, Department of Virology at the LMU Munich. The position is funded for 36 months (TV-L E13, 65%) and available in early / mid 2020.

If you would like to join, please send your application (letter of motivation, CV with publication list, certificates and 2 reference letters) by 15.02.2020.


Vir Biotechnology seeks a highly talented and motivated scientist to develop novel therapies for addressing unmet medical need in infectious diseases. This person will play a critical role in integrating the Company’s platform technologies into best-in-class anti-microbial products. This person will have significant interactions with other research departments for developing and leading new research strategies across multiple different viral and/or bacterial pathogens.